133 related articles for article (PubMed ID: 25911381)
1. Comments on "Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, α-PHPP and α-POP, with 11 newly distributed designer drugs in illegal products".
Tsujikawa K; Iwata YT; Inoue M; Higashibayashi S; Inoue H
Forensic Sci Int; 2015 Jun; 251():e15-7. PubMed ID: 25911381
[No Abstract] [Full Text] [Related]
2. Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, α-PHPP and α-POP, with 11 newly distributed designer drugs in illegal products.
Uchiyama N; Matsuda S; Kawamura M; Shimokawa Y; Kikura-Hanajiri R; Aritake K; Urade Y; Goda Y
Forensic Sci Int; 2014 Oct; 243():1-13. PubMed ID: 24769262
[TBL] [Abstract][Full Text] [Related]
3. [New psychotropic drugs - "legal highs"].
Scherbaum N; Schifano F; Siemann H
Fortschr Neurol Psychiatr; 2014 Sep; 82(9):532-43; quiz 543-4. PubMed ID: 25177905
[No Abstract] [Full Text] [Related]
4. Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry.
Shanks KG; Dahn T; Behonick G; Terrell A
J Anal Toxicol; 2012 Jul; 36(6):360-71. PubMed ID: 22586208
[TBL] [Abstract][Full Text] [Related]
5. [Current situation and issues for analyzing illegal drug products].
Hasegawa T; Takahashi K; Saijo M; Fukiwake T; Motoki Y
Yakugaku Zasshi; 2013; 133(1):7-11. PubMed ID: 23292013
[TBL] [Abstract][Full Text] [Related]
6. A synthetic cannabinoid FDU-NNEI, two 2
Uchiyama N; Shimokawa Y; Kikura-Hanajiri R; Demizu Y; Goda Y; Hakamatsuka T
Forensic Toxicol; 2015; 33(2):244-259. PubMed ID: 26257833
[TBL] [Abstract][Full Text] [Related]
7. 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs?
Auwärter V; Dresen S; Weinmann W; Müller M; Pütz M; Ferreirós N
J Mass Spectrom; 2009 May; 44(5):832-7. PubMed ID: 19189348
[No Abstract] [Full Text] [Related]
8. [Analysis of newly distributed designer drugs detected in the products purchased in fiscal year 2008].
Uchiyama N; Miyazawa N; Kawamura M; Kikura-Hanajiri R; Goda Y
Yakugaku Zasshi; 2010 Feb; 130(2):263-70. PubMed ID: 20118651
[TBL] [Abstract][Full Text] [Related]
9. Oral fluid drug analysis in the age of new psychoactive substances.
Øiestad EL; Øiestad ÅM; Gjelstad A; Karinen R
Bioanalysis; 2016 Apr; 8(7):691-710. PubMed ID: 26964619
[TBL] [Abstract][Full Text] [Related]
10. Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, Turkey.
Gurdal F; Asirdizer M; Aker RG; Korkut S; Gocer Y; Kucukibrahimoglu EE; Ince CH
J Forensic Leg Med; 2013 Aug; 20(6):667-72. PubMed ID: 23910858
[TBL] [Abstract][Full Text] [Related]
11. [Spice in France: mixed herbs containing synthetic cannabinoids].
Schlatter J; Chiadmi F; Chariot P
Ann Biol Clin (Paris); 2012; 70(4):413-22. PubMed ID: 22796613
[TBL] [Abstract][Full Text] [Related]
12. New designer drugs from the web.
Tuv SS; Krabseth HM; Strand MC; Karinen RA; Wiik E; Vevelstad MS; Westin AA; Øiestad EL; Vindenes V
Tidsskr Nor Laegeforen; 2016 May; 136(8):721-3. PubMed ID: 27143463
[No Abstract] [Full Text] [Related]
13. Phenazepam and cannabinomimetics sold as herbal highs in New Zealand.
Couch RA; Madhavaram H
Drug Test Anal; 2012 Jun; 4(6):409-14. PubMed ID: 22924168
[TBL] [Abstract][Full Text] [Related]
14. Rapid identification of synthetic cannabinoids in herbal samples via direct analysis in real time mass spectrometry.
Musah RA; Domin MA; Walling MA; Shepard JR
Rapid Commun Mass Spectrom; 2012 May; 26(9):1109-14. PubMed ID: 22467461
[TBL] [Abstract][Full Text] [Related]
15. DNA sequence analyses of blended herbal products including synthetic cannabinoids as designer drugs.
Ogata J; Uchiyama N; Kikura-Hanajiri R; Goda Y
Forensic Sci Int; 2013 Apr; 227(1-3):33-41. PubMed ID: 23092848
[TBL] [Abstract][Full Text] [Related]
16. Identification of a cannabinoid analog as a new type of designer drug in a herbal product.
Uchiyama N; Kikura-Hanajiri R; Kawahara N; Haishima Y; Goda Y
Chem Pharm Bull (Tokyo); 2009 Apr; 57(4):439-41. PubMed ID: 19336947
[TBL] [Abstract][Full Text] [Related]
17. The identification of synthetic cannabinoids surface coated on herbal substrates using solid-state nuclear magnetic resonance spectroscopy.
Burns NK; Theakstone AG; Zhu H; O'Dell LA; Pearson JR; Ashton TD; Pfeffer FM; Conlan XA
Anal Chim Acta; 2020 Apr; 1104():105-109. PubMed ID: 32106940
[TBL] [Abstract][Full Text] [Related]
18. Creation and application of psychoactive designer drugs data library using liquid chromatography with photodiode array spectrophotometry detector and gas chromatography-mass spectrometry.
Takahashi M; Nagashima M; Suzuki J; Seto T; Yasuda I; Yoshida T
Talanta; 2009 Feb; 77(4):1245-72. PubMed ID: 19084633
[TBL] [Abstract][Full Text] [Related]
19. [Increased abuse of the Internet drug MDPV in Västmanland. Severe cases of poisoning have given health care major problems].
Lindeman E; Hultén P; Ström S; Enlund M; Al-Saffar Y; Helander A
Lakartidningen; 2012 Oct 24-Nov 6; 109(43-44):1954-7. PubMed ID: 23198339
[No Abstract] [Full Text] [Related]
20. Synthetic cannabinoid 3-benzyl-5-[1-(2-pyrrolidin-1-ylethyl)-1H-indol-3-yl]-1,2,4-oxadiazole. The first detection in illicit market of new psychoactive substances.
Shevyrin V; Melkozerov V; Eltsov O; Shafran Y; Morzherin Y
Forensic Sci Int; 2016 Feb; 259():95-100. PubMed ID: 26771874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
